- Home
- WMB vs MDT Comparison
WMB vs MDT Comparison
Compare WMB & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WMB | MDT |
|---|---|---|
| Founded | 1908 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6B | 107.0B |
| IPO Year | 2002 | 2014 |
Fundamental Metrics
Financial Performance| Metric | WMB | MDT |
|---|---|---|
| Price | $75.13 | $92.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 21 |
| Target Price | $77.41 | ★ $108.21 |
| AVG Volume (30 Days) | 6.1M | ★ 6.5M |
| Earning Date | 05-04-2026 | 06-03-2026 |
| Dividend Yield | 2.86% | ★ 3.58% |
| EPS Growth | ★ 17.58 | 3.32 |
| EPS | 1.38 | ★ 3.73 |
| Revenue | $11,950,000,000.00 | ★ $36,364,000,000.00 |
| Revenue This Year | $6.97 | $8.91 |
| Revenue Next Year | $9.85 | $6.54 |
| P/E Ratio | $53.22 | ★ $24.29 |
| Revenue Growth | ★ 13.78 | 8.43 |
| 52 Week Low | $56.09 | $73.31 |
| 52 Week High | $80.08 | $106.33 |
Technical Indicators
Market Signals| Indicator | WMB | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 58.80 | 72.74 |
| Support Level | $72.17 | $85.35 |
| Resistance Level | $76.80 | $105.92 |
| Average True Range (ATR) | 1.70 | 1.89 |
| MACD | 0.46 | 0.41 |
| Stochastic Oscillator | 94.81 | 96.65 |
Price Performance
Historical ComparisonAbout WMB Williams Companies Inc. (The)
Williams operates the Transco pipeline, which connects the Gulf Coast to the Northeast United States. It has additional natural gas transmission pipelines connecting the Rockies to the Pacific Northwest and midcontinent. At the field level, it operates substantial gathering and processing assets in Appalachia and other basins. The company has also struck several power supply agreements.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.